470
Vol. 55, No. 3
nológico (CNPq–National Council for Scientific and Technological Devel-
opment) for the financial support provided. E.M.C. and C.R.N. are recipients
of CNPq research fellowships.
can be avoided by establishing the appropriate combination
of resin type, linker group and cleavage protocol used.
Experimental
References
All Fmoc amino acids were purchased from Advanced Chemtech
(Louisville, KY, U.S.A.) or Bachem Inc. (Torrance, CA, U.S.A.). Solvents
and reagents were acquired from Sigma-Aldrich Co. (St. Louis, MO, U.S.A.)
and Fluka (Buchs, Switzerland).
1) Merrifield R. B., J. Am. Chem. Soc., 85, 2149—2154 (1963).
2) Carpino L. A., J. Am. Chem. Soc., 115, 4397—4398 (1993).
3) Fara M. A., Mochón J. J. D., Bradley M., Tetrahedron Lett., 47, 1011—
1014 (2006).
Peptide Synthesis The peptides were synthesized manually according
to Fmoc chemistry. The following side-chain protecting groups were used:
t-butyl for Asp and Tyr residue; Pmc for Arg residue; and trityl for His
residue. In each synthetic cycle, the Na-Fmoc deprotection step was carried
out in 20% piperidine/DMF for 20 min, followed by washings with
dichloromethane (DCM) and DMF. The coupling reactions were performed
with a three-fold excess of the acylating component diisopropylcarbodi-
imide/N-hydroxybenzotriazole in DMF/DCM (1 : 1). After approximately
2 h of coupling, the ninhydrin test was performed to estimate the complete-
ness of the reaction. Cleavage from the resin and removal of the side-chain
protecting groups were simultaneously with different acid cocktails as de-
tailed below. After the cleavage procedure had been completed, the crude
peptides were precipitated with anhydrous ethyl ether, separated from the
soluble nonpeptide materials by centrifugation, extracted into 5% acetic acid
in water and lyophilized.
4) Varanda L. M., Miranda M. T. M., J. Pept. Res., 50, 102—108 (1997).
5) Ribeiro S. C. F., Schreier S., Nakaie C. R., Cilli E. M., Tetrahedron
Lett., 42, 3243—3246 (2001).
6) Milton R. C., Milton S. C. F., Adams P. A., J. Am. Chem. Soc., 112,
6039—6046 (1990).
7) Cilli E. M., Oliveira E., Marchetto R., Nakaie C. R., J. Org. Chem., 61,
8992—9000 (1996).
8) Malavolta L., Oliveira E., Cilli E. M., Nakaie C. R., Tetrahedron, 58,
4383—4394 (2002).
9) Malavolta L., Nakaie C. R., Tetrahedron, 60, 9417—9424 (2004).
10) Furrer J., Piotto M., Bourdonneau M., Limal D., Guichard G., Elbayed
K., Raya J., Briand J. P., Bianco A., J. Am. Chem. Soc., 123, 4130—
4138 (2001).
11) Valente A. P., Almeida F. C. L., Nakaie C. R., Schreier S., Crusca E.,
Cilli E. M., J. Pept. Sci., 11, 556—563 (2005).
Time-Course Cleavage Study In several small syringes, each equipped
with a polypropylene filter, the cleavage solution was added to isolated por-
tions (approximately 50 mg each) of protected peptide resins, stirred for 2 h
at 25 °C and cleaved using solvents 1 through 4 (see text). After the cleavage
reaction was complete, the resin was submitted to exhaustive washings with,
consecutively, ethyl ether, DCM, methanol (MeOH), 10% acetic acid
(AcOH)/water, water and MeOH to guarantee the removal of all cleaved
peptides and other by-products of the reaction. After this treatment, small
aliquots of each dried resin were hydrolyzed as previously reported34) for
further amino acid analysis. The calculated peptide content of the cleaved
resin was compared to the value obtained for the initial peptide-resin pair,
taken as 100%, and checked against the amount of cleaved peptide. To eval-
uate the purity of removed peptide, the cleaved peptide was isolated by pre-
cipitation with cold ethyl ether in the resin, further extracted with 10%
AcOH/water and lyophilized.
12) Hendrix J. C., Halverson K. J., Jarret J., Lansbury P. T., J. Org. Chem.,
55, 4517—4518 (1990).
13) Yan B., Acc. Chem. Res., 31, 621—630 (1998).
14) Cilli E. M., Marchetto R., Schreier S., Nakaie C. R., Tetrahedron Lett.,
38, 517—520 (1997).
15) Cilli E. M., Marchetto R., Schreier S., Nakaie C. R., J. Org. Chem., 64,
9118—9123 (1999).
16) Marchetto R., Cilli E. M., Jubilut G. N., Schreier S., Nakaie C. R., J.
Org. Chem., 70, 4561—4568 (2005).
17) Nakaie C. R., Malavolta L., Schreier S., Trovatti E., Marchetto R.,
Polymer, 47, 4531—4526 (2006).
18) Nakaie C. R., Goissis G., Schreier S., Paiva A. C. M., Braz. J. Med.
Biol. Res., 14, 173—180 (1981).
19) Marchetto R., Schreier S., Nakaie C. R., J. Am. Chem. Soc., 115,
11042—11043 (1993).
20) Stewart J. M., Young J. D., “Solid Phase Peptide Synthesis,” Pierce
Chemical Company, Rockford, IIIinois, 1984.
21) Barany G., Merrifield R. B., “Analysis, Synthesis and Biology,” ed. by
Gross E., Meinhofer J., Academic Press, New York, 1980.
22) Jubilut G. N., Miranda M. T., Tominaga M., Okada Y., Miranda A.,
Nakaie C. R., Chem. Pharm. Bull., 47, 1560—1563 (1999).
23) Jubilut G. N., Cilli E. M., Tominaga M., Miranda A., Okada Y., Nakaie
C. R., Chem. Pharm. Bull., 49, 1089—1092 (2001).
24) Sakakibara S., Shimonishi Y., Kishida Y., Okada M., Sugihara H.,
Bull. Chem. Soc. Jpn., 40, 2164—2167 (1968).
25) Yajima H., Fujii N., Ogawa H., Kawatani H., Chem. Commun., 1974,
107—108 (1974).
26) Pietta P. G., Cavallo P. F., Takahashi K., Marshall G. R., J. Org. Chem.,
39, 44—48 (1974).
27) Matsueda G. R., Stewart J. M., Peptides, 2, 45—50 (1981).
28) Fields G. B., Noble R. L., Int. J. Peptide Protein Res., 35, 161—214
(1990).
29) Wang S. S., J. Am. Chem. Soc., 95, 1328—1333 (1973).
30) King D. S., Fields C. G., Fields G. B., Int. J. Peptide Protein Res., 36,
255—266 (1990).
31) Bernatowicz M. S., Daniels S. B., Koster H., Tetrahedron Lett., 30,
4645—4648 (1989).
32) Rink H., Tetrahedron Lett., 28, 3787—3790 (1987).
33) Kates S. A., Albericio F., “Solid Phase Synthesis: a Practical Guide,”
Marcel Dekker, New York, 2000, pp. 275—330.
Amino Acid Analysis As recently proposed,34) prior to cleavage, all
peptide-resin pairs were hydrolyzed with a mixture of 12 N HCl/propionic
acid for 100 h at 130 °C to guarantee quantitative removal of peptide chains
from the resin. Pyrex tubes with plastic Teflon-coated screw caps (13ꢁ1 cm)
were used for the hydrolyses, and the amino acid analyses were performed in
a Biochrom 20 plus amino acid analyzer (Pharmacia LKB Biochrom Ltd.,
Cambridge, England) to determine the amount of peptide attached to the
resin.
Analytical RP-HPLC The RP-HPLC analyses were carried out in
TFA/acetonitrile gradient using a Waters Associates HPLC system consist-
ing of two 510 HPLC pumps, automated gradient controller, Rheodyne man-
ual injector, 486 UV detector and 746 data module (Waters, Eschborn, Ger-
many). We used Solvent A (0.1% TFA/H2O) and Solvent B (60% acetoni-
trile/0.1% TFA/H2O with a gradient of 5—95% in 30 min) at a flow rate of
1.5 ml/min. A C18 column (0.46ꢁ25 cm, 5 mm particle size and 300 Å pore
size; Vydac, Hesperia, CA, U.S.A.) was employed. Detection was at lꢂ
210 nm.
Liquid Chromatography/Mass Spectrometry The crude lyophilized
peptides were analyzed on a system composed of a Micromass Platform
LCZ Mass Spectrometer (Micromass, Manchester, U.K.), a Waters Alliance
HPLC, a Waters 996 Photodiode Array detector, and a Compaq Workstation.
The peptides were loaded onto a Waters Nova-Pak C18 reverse-phase HPLC
column (2.1ꢁ150 mm, 3.5 mm particle size and 60 Å pore size), using Sol-
vents A (0.1% TFA/H2O) and B (0.1% TFA in CH3CN/H2O) at a flow rate of
0.4 ml/min, detection at 210 nm and a mass range of 500—3930 Daltons.
34) Jubilut G. N., Marchetto R., Cilli E. M., Oliveira E., Miranda A., Tom-
inaga M., Nakaie C. R., J. Braz. Chem. Soc., 8, 65—70 (1997).
35) Núria A., Barany G., J. Org. Chem., 57, 5399—5403 (1992).
Acknowledgments We thank the Fundação de Amparo à Pesquisa do
Estado de São Paulo (Foundation for the Support of Research in the state of
São Paulo) and the Conselho Nacional de Desenvolvimento Científico e Tec-